Capital Fund Management (CFM)
SRPT icon

Capital Fund Management (CFM)’s Sarepta Therapeutics SRPT Stock Holding History

Capital Fund Management (CFM)’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41M Sell
65,000
-88,000
-58% -$1.7M 0.01% 1528
2025
Q4 		$3.29M Sell
153,000
-77,300
-34% -$1.63M 0.01% 1435
2025
Q3 		$4.44M Buy
230,300
+168,400
+272% +$3M 0.01% 1316
2025
Q2 		$1.06M Buy
+61,900
New +$2.64M ﹤0.01% 1981
2020
Q1 		– Sell
-14,000
Closed -$1.81M – 1990
2019
Q4 		$1.81M Buy
14,000
+500
+4% +$50.5K 0.01% 876
2019
Q3 		$1.02M Hold
13,500
– – 0.01% 1011
2019
Q2 		$2.05M Hold
13,500
– – 0.02% 791
2019
Q1 		$1.61M Sell
13,500
-37,100
-73% -$4.77M 0.01% 889
2018
Q4 		$5.52M Sell
50,600
-6,800
-12% -$850K 0.05% 475
2018
Q3 		$9.27M Buy
57,400
+51,200
+826% +$7M 0.05% 523
2018
Q2 		$820K Buy
6,200
+800
+15% +$75.4K ﹤0.01% 1406
2018
Q1 		$400K Sell
5,400
-2,500
-32% -$167K ﹤0.01% 1532
2017
Q4 		$440K Sell
7,900
-5,400
-41% -$286K ﹤0.01% 1506
2017
Q3 		$603K Sell
13,300
-2,700
-17% -$108K ﹤0.01% 1129
2017
Q2 		$539K Sell
16,000
-53,200
-77% -$1.73M ﹤0.01% 1105
2017
Q1 		$2.05M Buy
+69,200
New +$2.14M 0.02% 723
2013
Q4 		– Sell
-8,200
Closed -$387K – 1831
2013
Q3 		$387K Buy
+8,200
New +$316K 0.01% 1256

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Fund Management (CFM)'s SRPT Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Sarepta Therapeutics (SRPT) stake by 5.4% in Q1 2026, selling an estimated $506K and leaving 459,322 shares worth $9.99M. The position accounts for 0.05% of the portfolio, ranked #553.

Capital Fund Management (CFM) first reported a position in SRPT in Q3 2013 and has held it in 27 quarters since. The position peaked at $25.5M in Q3 2024. 340 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Capital Fund Management (CFM) held 459,322 shares of Sarepta Therapeutics worth $9.99M as of Q1 2026.
  • Capital Fund Management (CFM) sold 26,131 Sarepta Therapeutics shares in Q1 2026, an estimated $506K.
  • Sarepta Therapeutics made up 0.05% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #553 holding.
  • Capital Fund Management (CFM) first reported a position in Sarepta Therapeutics in Q3 2013 and has held it in 27 quarters since.
  • Capital Fund Management (CFM)'s Sarepta Therapeutics position peaked at $25.5M in Q3 2024.
  • 340 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.